{"id":"W4405659418","doi":"10.1093/brain/awae409","title":"De-escalating and discontinuing disease-modifying therapies in multiple sclerosis","year":2024,"lang":"en","type":"review","venue":"Brain","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Cilag; Instituto de Salud Carlos III; Janssen Pharmaceuticals; Sanofi Genzyme; Chugai Pharmaceutical; Novartis Pharma; Strategic Research Council; EMD Serono; MedDay Pharmaceuticals; Tays; University College London Hospitals NHS Foundation Trust; Deutsche Forschungsgemeinschaft; Bayer HealthCare; Multiple Sclerosis Society; National Institute for Health and Care Research; Galápagos; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Argenx; Celltrion; Shionogi; Merck KGaA; Kiniksa Pharmaceuticals; National Institutes of Health; Mylan; H. Lundbeck A/S; Horizon Therapeutics; Monash University; Sanofi; TG Therapeutics; Genentech; European Commission; Fondation Brain Canada; European Committee for Treatment and Research in Multiple Sclerosis; Bundesministerium für Bildung und Forschung; Max-Planck-Gesellschaft; Atara Biotherapeutics; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Biogen; Agence Nationale de la Recherche; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Bristol-Myers Squibb; Teva Pharmaceutical Industries; Eli Lilly and Company; U.S. Department of Defense; Multiple Sclerosis International Federation; Celgene; Moderna; International Progressive MS Alliance; National Multiple Sclerosis Society; Istanbul Üniversitesi-Cerrahpasa; GlaxoSmithKline; Patient-Centered Outcomes Research Institute; Amgen","keywords":"Multiple sclerosis; Medicine; Disease; Intensive care medicine; Modalities; Psychiatry; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007450141,0.0003175354,0.001026094,0.0003562396,0.0001004945,0.0001414099,0.0001022446,0.00009659354,0.00001627504],"category_scores_gemma":[0.002192397,0.0002271347,0.0002563462,0.0004139923,0.0001455189,0.00008451651,0.0002542921,0.0005007444,0.00001766853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001730184,"about_ca_system_score_gemma":0.0001711819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006722712,"about_ca_topic_score_gemma":0.00005566538,"domain_scores_codex":[0.9981397,0.0001971651,0.0004327023,0.0004844589,0.0002602971,0.0004856189],"domain_scores_gemma":[0.998517,0.0009092684,0.00006986437,0.0002574524,0.00002138513,0.0002250477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001275848,0.00003161305,0.004861357,0.01690577,0.0001406114,0.00004964976,0.0008807312,2.609883e-7,0.00004674227,0.00008028027,0.000187388,0.9768028],"study_design_scores_gemma":[0.001907323,0.0000812935,0.09836852,0.2373291,0.0009440838,0.00003946015,0.00102308,0.002464278,0.00000224489,0.0001218057,0.6568797,0.000839074],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003116279,0.9946055,0.00003595727,0.0008802766,0.00004981933,0.0009636359,0.00002848559,0.00009448255,0.0002256106],"genre_scores_gemma":[0.02972298,0.9687313,0.0006789298,0.00006845057,0.0001835883,0.0002025629,0.0000125626,0.00006872747,0.0003308714],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9759638,"threshold_uncertainty_score":0.9262285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2073639087695125,"score_gpt":0.3964255736704481,"score_spread":0.1890616649009356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}